1. Home
  2. PVLA vs CENTA Comparison

PVLA vs CENTA Comparison

Compare PVLA & CENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Palvella Therapeutics Inc.

PVLA

Palvella Therapeutics Inc.

HOLD

Current Price

$151.21

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo Central Garden & Pet Company Nonvoting

CENTA

Central Garden & Pet Company Nonvoting

HOLD

Current Price

$34.65

Market Cap

2.3B

ML Signal

HOLD

Company Overview

Basic Information
Metric
PVLA
CENTA
Founded
2015
1955
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Consumer Specialties
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.3B
IPO Year
2013
1996

Fundamental Metrics

Financial Performance
Metric
PVLA
CENTA
Price
$151.21
$34.65
Analyst Decision
Strong Buy
Hold
Analyst Count
15
4
Target Price
$171.87
$36.75
AVG Volume (30 Days)
160.3K
256.4K
Earning Date
05-12-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
52.62
57.41
EPS
N/A
2.84
Revenue
$42,810,000.00
$3,129,100,000.00
Revenue This Year
N/A
$1.60
Revenue Next Year
$104,350.18
$2.04
P/E Ratio
N/A
$12.34
Revenue Growth
65.28
N/A
52 Week Low
$56.55
$25.97
52 Week High
$161.38
$40.80

Technical Indicators

Market Signals
Indicator
PVLA
CENTA
Relative Strength Index (RSI) 50.36 33.57
Support Level $145.91 $33.55
Resistance Level $151.18 $35.28
Average True Range (ATR) 5.61 1.09
MACD -0.27 -0.09
Stochastic Oscillator 51.04 18.30

Price Performance

Historical Comparison
PVLA
CENTA

About PVLA Palvella Therapeutics Inc.

Palvella Therapeutics Inc is a clinical-stage biopharmaceutical company whose vision is to become the rare disease biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare skin diseases and vascular malformations for which there are no FDA-approved therapies. Its product candidate, QTORIN 3.9% rapamycin anhydrous gel, is currently in clinical development for microcystic lymphatic malformations and cutaneous venous malformations. It operates in single segment.

About CENTA Central Garden & Pet Company Nonvoting

Central Garden & Pet Co offers solutions that support healthier pets, greener lawns, and thriving gardens. Its products include dog and cat treats, chews, toys, beds, containment, grooming supplies, aquatics, small animal and bird supplies, equine and livestock products, insect control solutions, grass seed, wild bird feed, fertilizers, pest controls, live plants, and packet seeds, sold under brands such as Aqueon, Nylabone, Kaytee, Farnam, Pennington, Ferry Morse, Amdro, and Sevin. The company operates through two segments, Pet and Garden, and sells through retailers, independent stores, eCommerce channels, and professional markets. It has sales and distribution operations mainly across the United States, with additional facilities in Canada and Mexico.

Share on Social Networks: